Timothy Kelly

Timothy Kelly

Chief Tech/Sci/R&D Officer at CARIBOU BIOSCIENCES, INC.

Net worth: 172 575 $ as of 2026-05-30

57 year
Health Technology
Consumer Services
Producer Manufacturing

Profile

Timothy P.
Kelly
currently works at Caribou Biosciences, Inc., as Chief Technology Officer from 2024.
Mr. Kelly also formerly worked at Oxford Biomedica Solutions LLC, as Chairman & Chief Executive Officer from 2022 to 2023, Biogen, Inc., as Senior Director-International Operations from 1998 to 2005, Sarepta Therapeutics, Inc., as Head-Technical Operations in 2017, Shire Plc, as Senior Vice President & Head-Biologics Operating from 2016 to 2017, UCB SA, as Head-Technical Operations from 2005 to 2009, and Homology Medicines, Inc., as Chief Operating Officer from 2021 to 2022.
Mr. Kelly received his undergraduate degree from United States Air Force Academy and Masters Business Admin degree from Troy University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-02-24 73,125 ( 0.07% ) 172 575 $ 2026-05-30

Timothy Kelly active positions

CompaniesPositionStart
CARIBOU BIOSCIENCES, INC. Chief Tech/Sci/R&D Officer 2024-01-06

Former positions of Timothy Kelly

CompaniesPositionEnd
Chief Executive Officer 2023-06-30
Q32 BIO INC. Chief Operating Officer 2022-03-09
SAREPTA THERAPEUTICS, INC. Corporate Officer/Principal 2017-04-30
SHIRE Corporate Officer/Principal 2016-12-31
UCB Corporate Officer/Principal 2008-12-31
See the detail of Timothy Kelly's experience

Training of Timothy Kelly

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

73

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Producer Manufacturing

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!